CAR T-Cell Antigen-Non-Specific Killing (CTAK), CAR-T NK-Like Killing, and CD22 CAR-T Mediated Killing Are All Optimized by Bryostatin Treatment of Pre-B Acute Lymphocytic Leukemia Cell Lines
MOLECULAR THERAPY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要